IBG BECAME ONE OF THE PARTNERS OF THE NANOBIO4CAN PROJECT
The kick-off meeting of the Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer (NANOBIO4CAN) Project, of which we are a partner, was held with the presentation of TÜBİTAK President Prof. Dr. Hasan Mandal.
At the meeting, where the partners of the NANOBIO4CAN Project, which is funded by the European Commission and co-financed by TÜBİTAK, will be carried out under the coordination of SUNUM, in partnership with TUBITAKMAM, KUTTAM and IBG, signed the cooperation protocol, Prof. Dr. Bayram Yılmaz, Director of IBG, also shared the activities to be carried out by the center within the scope of the project.
The NANOBIO4CAN Project, which is a mobility scholarship program for postdoctoral researchers within the scope of Marie Sklodowska-Curie - COFUND under the scientific excellence component of the Horizon Europe Program, aims to conduct postdoctoral research on drug development, drug delivery and target systems development, testing and validation systems.
In addition to academic studies focused on cancer research, the project is also an accelerator program specifically designed to develop an entrepreneurial mindset in early-stage researchers.